Fungal Pathogens in CF Airways: Leave or Treat?

Area of Science:

• Pulmonary Medicine
• Infectious Diseases
• Microbiology

Background:

• Chronic airway infections are central to cystic fibrosis (CF) lung disease progression.
• Bacterial pathogens like Pseudomonas aeruginosa have historically dominated research, but fungal presence is common.
• Emerging evidence suggests fungi, including Aspergillus fumigatus and Candida albicans, may influence CF lung disease.

Purpose of the Study:

• To review the pathophysiological mechanisms and clinical impact of fungal presence in CF airways.
• To differentiate between fungal colonization, sensitization, and infection in the context of CF lung disease.
• To summarize current understanding of fungal-host interactions in CF.

Main Methods:

• Literature review of in vitro and in vivo studies.
• Analysis of clinical data associating fungal presence with CF lung disease course.
• Discussion of immune response mechanisms in CF airways towards fungi.

Main Results:

• Fungi are frequently detected in CF airways, with Aspergillus fumigatus and Candida albicans being common.
• Impaired immune responses in CF patients may increase susceptibility to fungal pathogens.
• The precise role of fungi—whether active participants or bystanders—in CF lung disease pathology remains under investigation.

Conclusions:

• Fungi represent a significant, yet not fully understood, factor in cystic fibrosis lung disease.
• Distinguishing fungal colonization from active infection is crucial for understanding their impact.
• Further research is needed to elucidate the mechanisms and clinical significance of fungal-host interactions in CF.